{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T16:50:30Z","timestamp":1789404630817,"version":"build-2803163510"},"reference-count":144,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:00:00Z","timestamp":1761868800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Neurosci."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a neurodegenerative disorder increasingly associated with alterations in gut microbiota through the gut\u2013brain axis (GBA). Despite growing global interest, studies examining microbiota composition in Eastern European populations remain limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We profiled the gut microbiota of 59 Romanian individuals using 16S rRNA gene sequencing targeting the V3\u2013V4 region. After quality filtering, 39 subjects (19 PD patients and 20 healthy controls [HC]) were retained for downstream analysis. Clinical metadata were collected to assess potential confounders, including age, sex, metabolic parameters, lifestyle, and comorbidities.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      PD patients differed significantly from HCs in glycemia (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.02), cholesterol (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.027), and LDL levels (\n                      <jats:italic>p<\/jats:italic>\n                      = 0.047), and more frequently presented with restrictive diets and comorbidities such as cardiovascular disease and diabetes. While \u03b1-diversity metrics did not differ significantly between groups, principal coordinate analysis (PCoA) based on Aitchison distance showed moderate compositional separation. Permutational multivariate analysis of variance (PERMANOVA) confirmed that disease status was a significant driver of gut microbiota composition (\n                      <jats:italic>R<\/jats:italic>\n                      <jats:sup>2<\/jats:sup>\n                      = 5.3%,\n                      <jats:italic>p<\/jats:italic>\n                      = 0.002), independent of clinical and lifestyle covariates. Sparse partial least square linear discriminant (sPLS-DA) identified several genera distinguishing PD from HC, with\n                      <jats:italic>Mogibacterium<\/jats:italic>\n                      and\n                      <jats:italic>RikenellaceaeRC9<\/jats:italic>\n                      gut group enriched in PD, and several known short-chain fatty acid (SCFA)-producing genera (\n                      <jats:italic>Fusicatenibacter<\/jats:italic>\n                      ,\n                      <jats:italic>Lachnospiraceae UCG-001<\/jats:italic>\n                      ,\n                      <jats:italic>Butyricicoccus<\/jats:italic>\n                      ,\n                      <jats:italic>Anaerostipes<\/jats:italic>\n                      ) enriched in HCs. Linear discriminant analysis (LDA) Effect Size (LEfSe) corroborated these findings, confirming the differential abundance of several SCFA-producing genera in the HC group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Our results reveal distinct microbial signatures associated with PD in this Romanian cohort, marked by a consistent depletion of SCFA-producing bacteria in patients. These findings support the role of gut microbiota in PD pathophysiology and underscore the need for further studies in Eastern European populations.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnins.2025.1654995","type":"journal-article","created":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:25:32Z","timestamp":1761891932000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring gut microbiota alterations in Parkinson\u2019s disease: insights from a 16S amplicon sequencing Eastern European pilot study"],"prefix":"10.3389","volume":"19","author":[{"given":"Ovidiu-Dumitru","family":"Ilie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina-Cezara","family":"V\u0103c\u0103rean-Trandafir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana-Maria","family":"Am\u0103randi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilinca-Bianca","family":"Nita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petru-Romeo","family":"Dobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Doroftei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iuliu-Cristian","family":"Ivanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gheorghe","family":"Savuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kirov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bogdan","family":"Doroftei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,10,31]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13024-021-00427-6","article-title":"Relationships of gut microbiota, short-chain fatty acids, inflammation, and the gut barrier in Parkinson\u2019s disease","volume":"16","author":"Aho","year":"2021","journal-title":"Mol. Neurodegener."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.ebiom.2019.05.064","article-title":"Gut microbiota in Parkinson\u2019s disease: temporal stability and relations to disease progression","volume":"44","author":"Aho","year":"2019","journal-title":"EBioMedicine"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"115321","DOI":"10.1016\/j.ecoenv.2023.115321","article-title":"Altered gut microbiota community structure and correlated immune system changes in dibutyl phthalate exposed mice","volume":"262","author":"Almamoun","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1007\/s13760-023-02195-0","article-title":"Altered gut microbiota in patients with idiopathic Parkinson\u2019s disease: an age-sex matched case-control study","volume":"123","author":"Babacan Yildiz","year":"2023","journal-title":"Acta Neurol. Belg."},{"key":"ref5","doi-asserted-by":"publisher","first-page":"112444","DOI":"10.1016\/j.exger.2024.112444","article-title":"Association between increased and decreased gut microbiota abundance and Parkinson\u2019s disease: a systematic review and subgroup meta-analysis","volume":"191","author":"Bai","year":"2024","journal-title":"Exp. Gerontol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12915-020-00775-7","article-title":"Parkinson\u2019s disease-associated alterations of the gut microbiome predict disease-relevant changes in metabolic functions","volume":"18","author":"Baldini","year":"2020","journal-title":"BMC Biol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/WNL.0000000000003127","article-title":"Probiotics and prebiotic fiber for constipation associated with Parkinson disease","volume":"87","author":"Barichella","year":"2016","journal-title":"Neurology"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism","volume":"34","author":"Barichella","year":"2019","journal-title":"Mov. Disord."},{"key":"ref9","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s13073-017-0428-y","article-title":"Functional implications of microbial and viral gut metagenome changes in early stage L-DOPA-na\u00efve Parkinson\u2019s disease patients","volume":"9","author":"Bedarf","year":"2017","journal-title":"Genome Med."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/S0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1038\/s41531-022-00395-8","article-title":"Fecal microbiome alterations in treatment-naive de novo Parkinson\u2019s disease","volume":"8","author":"Boertien","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"III\/1","DOI":"10.1007\/s00415-002-1301-4","article-title":"Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson\u2019s disease (preclinical and clinical stages)","author":"Braak","year":"2002","journal-title":"J. Neurol."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"","journal-title":"Neurobiol. Aging"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1007\/s00702-002-0808-2","article-title":"Idiopathic Parkinson\u2019s disease: possible routes by which vulnerable neuronal types may be subject to neuroinvasion by an unknown pathogen","volume":"110","author":"Braak","year":"","journal-title":"J. Neural Transm."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.12688\/f1000research.8986.2","article-title":"Bioconductor workflow for microbiome data analysis: from raw reads to community analyses","volume":"5","author":"Callahan","year":"2016","journal-title":"F1000Res"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"4027","DOI":"10.1093\/bioinformatics\/btac438","article-title":"microbiomeMarker: an R\/Bioconductor package for microbiome marker identification and visualization","volume":"38","author":"Cao","year":"2022","journal-title":"Bioinformatics"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1186\/1471-2180-12-158","article-title":"Storage conditions of intestinal microbiota matter in metagenomic analysis","volume":"12","author":"Cardona","year":"2012","journal-title":"BMC Microbiol."},{"key":"ref18","doi-asserted-by":"publisher","first-page":"476041","DOI":"10.1155\/2015\/476041","article-title":"Gastrointestinal biopsies for the diagnosis of alpha-Synuclein pathology in Parkinson\u2019s disease","volume":"2015","author":"Cersosimo","year":"2015","journal-title":"Gastroenterol. Res. Pract."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/j.1365-2036.2012.05007.x","article-title":"Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome","volume":"35","author":"Chassard","year":"2012","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson\u2019s disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol."},{"key":"ref21","first-page":"13710","article-title":"An analysis of the characteristics of the intestinal flora in patients with Parkinson\u2019s disease complicated with constipation","volume":"13","author":"Chen","year":"2021","journal-title":"Am. J. Transl. Res."},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2106","DOI":"10.1093\/bioinformatics\/bts342","article-title":"Associating microbiome composition with environmental covariates using generalized UniFrac distances","volume":"28","author":"Chen","year":"2012","journal-title":"Bioinformatics"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"e848","DOI":"10.1212\/WNL.0000000000013225","article-title":"Association of Fecal and Plasma Levels of short-chain fatty acids with gut microbiota and clinical severity in patients with Parkinson disease","volume":"98","author":"Chen","year":"2022","journal-title":"Neurology"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"16350","DOI":"10.1038\/srep16350","article-title":"Sample storage conditions significantly influence faecal microbiome profiles","volume":"5","author":"Choo","year":"2015","journal-title":"Sci. Rep."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"159","DOI":"10.3233\/JPD-202297","article-title":"Does gut microbiota influence the course of Parkinson\u2019s disease? A 3-year prospective exploratory study in de novo patients","volume":"11","author":"Cilia","year":"2021","journal-title":"J. Parkinsons Dis."},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1002\/mds.28052","article-title":"Microbiota composition and metabolism are associated with gut function in Parkinson\u2019s disease","volume":"35","author":"Cirstea","year":"2020","journal-title":"Mov. Disord."},{"key":"ref27","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/978-3-642-30138-4_343","volume-title":"The family coriobacteriaceae BT - the prokaryotes: Actinobacteria","author":"Clavel","year":"2014"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/nrn3346","article-title":"Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour","volume":"13","author":"Cryan","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1038\/s41575-019-0157-3","article-title":"The role of short-chain fatty acids in microbiota\u2013gut\u2013brain communication","volume":"16","author":"Dalile","year":"2019","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/S0896-6273(03)00568-3","article-title":"Parkinson\u2019s disease: mechanisms and models","volume":"39","author":"Dauer","year":"2003","journal-title":"Neuron"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.2217\/fmb-2019-0336","article-title":"The impact of intestinal microbiota on weight loss in Parkinson\u2019s disease patients: a pilot study","volume":"15","author":"Del Chierico","year":"2020","journal-title":"Future Microbiol."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"wrae106","DOI":"10.1093\/ismejo\/wrae106","article-title":"Nonparametric richness estimators Chao1 and ACE must not be used with amplicon sequence variant data","volume":"18","author":"Deng","year":"2024","journal-title":"ISME J."},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","article-title":"Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria","volume":"8","author":"Dickson","year":"2009","journal-title":"Lancet Neurol."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/S1474-4422(18)30295-3","article-title":"Global, regional, and national burden of Parkinson\u2019s disease, 1990\u20132016: a systematic analysis for the global burden of disease study 2016","volume":"17","author":"Dorsey","year":"2018","journal-title":"Lancet Neurol."},{"key":"ref35","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.4103\/1673-5374.300980","article-title":"Oxidative stress factors in Parkinson\u2019s disease","volume":"16","author":"Dorszewska","year":"2021","journal-title":"Neural Regen. Res."},{"key":"ref36","doi-asserted-by":"publisher","first-page":"689723","DOI":"10.3389\/fnins.2021.689723","article-title":"Serum and fecal markers of intestinal inflammation and intestinal barrier permeability are elevated in Parkinson\u2019s disease","volume":"15","author":"Dumitrescu","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1104759","DOI":"10.3389\/fneur.2023.1104759","article-title":"Fecal microbiota transplantation in Parkinson\u2019s disease-a randomized repeat-dose, placebo-controlled clinical pilot study","volume":"14","author":"DuPont","year":"2023","journal-title":"Front. Neurol."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.neurol.2015.09.012","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"172","author":"Elbaz","year":"2016","journal-title":"Rev. Neurol."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1007\/s40120-022-00435-8","article-title":"Off-time treatment options for Parkinson\u2019s disease","volume":"12","author":"Fabbri","year":"2023","journal-title":"Neurol. Ther."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"e28032","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson\u2019s disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"837019","DOI":"10.3389\/fcimb.2022.837019","article-title":"A pilot study exploring the Association of Entacapone, gut microbiota, and the subsequent side effects in patients with Parkinson\u2019s disease","volume":"12","author":"Fu","year":"","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref42","doi-asserted-by":"publisher","first-page":"871710","DOI":"10.3389\/fcimb.2022.871710","article-title":"Exploring the causal effect of constipation on Parkinson\u2019s disease through mediation analysis of microbial data","volume":"12","author":"Fu","year":"","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3389\/fmicb.2017.01221","article-title":"The gut microbiota of healthy Chilean subjects reveals a high abundance of the phylum Verrucomicrobia","volume":"8","author":"Fujio-Vejar","year":"2017","journal-title":"Front. Microbiol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.3389\/fmicb.2018.01250","article-title":"Body mass index differences in the gut microbiota are gender specific","volume":"9","author":"Gao","year":"2018","journal-title":"Front. Microbiol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/microorganisms6030075","article-title":"Akkermansia muciniphila in the human gastrointestinal tract: when, where, and how?","volume":"6","author":"Geerlings","year":"2018","journal-title":"Microorganisms"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"100087","DOI":"10.1016\/j.ijpx.2021.100087","article-title":"Influence of probiotic bacteria on gut microbiota composition and gut wall function in an in-vitro model in patients with Parkinson\u2019s disease","volume":"3","author":"Ghyselinck","year":"2021","journal-title":"Int. J. Pharm. X"},{"key":"ref47","doi-asserted-by":"publisher","first-page":"39399","DOI":"10.1038\/srep39399","article-title":"The human intestinal microbiota of constipated-predominant irritable bowel syndrome patients exhibits anti-inflammatory properties","volume":"6","author":"Gobert","year":"2016","journal-title":"Sci. Rep."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1080\/19490976.2017.1406584","article-title":"Low dietary fiber intake increases Collinsella abundance in the gut microbiota of overweight and obese pregnant women","volume":"9","author":"Gomez-Arango","year":"2018","journal-title":"Gut Microbes"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"e14846","DOI":"10.1111\/nmo.14846","article-title":"Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson\u2019s disease patients","volume":"36","author":"Gorecka-Mazur","year":"2024","journal-title":"Neurogastroenterol. Motil."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.3390\/microorganisms10051020","article-title":"Dynamics of changes in the gut microbiota of healthy mice fed with lactic acid Bacteria and Bifidobacteria","volume":"10","author":"Gryaznova","year":"2022","journal-title":"Microorganisms"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"875101","DOI":"10.3389\/fmicb.2022.875101","article-title":"Integrated microbiome and host transcriptome profiles link Parkinson\u2019s disease to Blautia genus: evidence from feces, blood, and brain","volume":"13","author":"Guo","year":"2022","journal-title":"Front. Microbiol."},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal Dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson\u2019s disease","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS One"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1111\/j.1365-2990.2007.00874.x","article-title":"Parkinson\u2019s disease: a dual-hit hypothesis","volume":"33","author":"Hawkes","year":"2007","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"ref54","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1749-6632.2009.04365.x","article-title":"Parkinson\u2019s disease","volume":"1170","author":"Hawkes","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.parkreldis.2009.08.007","article-title":"A timeline for Parkinson\u2019s disease","volume":"16","author":"Hawkes","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref56","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/mds.27105","article-title":"The nasal and gut microbiome in Parkinson\u2019s disease and idiopathic rapid eye movement sleep behavior disorder","volume":"33","author":"Heintz-Buschart","year":"2018","journal-title":"Mov. Disord."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13024-023-00676-7","article-title":"Mitochondrial dysfunction in Parkinson\u2019s disease \u2013 a key disease hallmark with therapeutic potential","volume":"18","author":"Henrich","year":"2023","journal-title":"Mol. Neurodegener."},{"key":"ref58","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1016\/j.celrep.2019.10.035","article-title":"Integrated analyses of microbiome and longitudinal metabolome data reveal microbial-host interactions on sulfur metabolism in Parkinson\u2019s disease","volume":"29","author":"Hertel","year":"2019","journal-title":"Cell Rep."},{"key":"ref59","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1002\/mds.26942","article-title":"Parkinson\u2019s disease and Parkinson\u2019s disease medications have distinct signatures of the gut microbiome","volume":"32","author":"Hill-Burns","year":"2017","journal-title":"Mov. Disord."},{"key":"ref60","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41564-020-0743-8","article-title":"Genome-wide associations of human gut microbiome variation and implications for causal inference analyses","volume":"5","author":"Hughes","year":"2020","journal-title":"Nat. Microbiol."},{"key":"ref61","volume-title":"16S metagenomic sequencing library preparation","year":"2013"},{"key":"ref62","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/ejn.14952","article-title":"Leveraging sequence-based faecal microbial community survey data to identify alterations in gut microbiota among patients with Parkinson\u2019s disease","volume":"53","author":"Ji","year":"2021","journal-title":"Eur. J. Neurosci."},{"key":"ref63","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41531-022-00351-6","article-title":"Oral and gut dysbiosis leads to functional alterations in Parkinson\u2019s disease","volume":"8","author":"Jo","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1093\/bioinformatics\/btq166","article-title":"Picante: R tools for integrating phylogenies and ecology","volume":"26","author":"Kembel","year":"2010","journal-title":"Bioinformatics"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"756951","DOI":"10.3389\/fnins.2021.756951","article-title":"Changes in the gut microbiome and predicted functional metabolic effects in an Australian Parkinson\u2019s disease cohort","volume":"15","author":"Kenna","year":"2021","journal-title":"Front. Neurosci."},{"key":"ref66","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson\u2019s disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"575","DOI":"10.4196\/kjpp.2021.25.6.575","article-title":"Aging effects on the diurnal patterns of gut microbial composition in male and female mice","volume":"25","author":"Kim","year":"2021","journal-title":"Korean J. Physiol. Pharmacol."},{"key":"ref68","doi-asserted-by":"publisher","first-page":"R832","DOI":"10.1016\/j.cub.2016.08.015","article-title":"Gut microbiota signatures of longevity","volume":"26","author":"Kong","year":"2016","journal-title":"Curr. Biol."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/s12934-021-01589-0","article-title":"Evaluation of fecal microbiota transplantation in Parkinson\u2019s disease patients with constipation","volume":"20","author":"Kuai","year":"2021","journal-title":"Microb. Cell Factories"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"956440","DOI":"10.3389\/fneur.2022.956440","article-title":"Worldwide trends in mortality related to Parkinson\u2019s disease in the period of 1994-2019: analysis of vital registration data from the WHO mortality database","volume":"13","author":"Lampropoulos","year":"2022","journal-title":"Front. Neurol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1136\/gutjnl-2020-322429","article-title":"Inflammatory bowel disease and Parkinson\u2019s disease: common pathophysiological links","volume":"70","author":"Lee","year":"2021","journal-title":"Gut"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"101834","DOI":"10.1016\/j.arr.2022.101834","article-title":"Premotor, nonmotor and motor symptoms of Parkinson\u2019s disease: a new clinical state of the art","volume":"84","author":"Leite Silva","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fnmol.2019.00171","article-title":"Gut microbiota differs between Parkinson\u2019s disease patients and healthy controls in Northeast China","volume":"12","author":"Li","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/cns.13990","article-title":"Gut bacterial profiles in Parkinson\u2019s disease: a systematic review","volume":"29","author":"Li","year":"2023","journal-title":"CNS Neurosci. Ther."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"632482","DOI":"10.3389\/fimmu.2021.632482","article-title":"Altered Actinobacteria and Firmicutes phylum associated epitopes in patients with Parkinson\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Front. Immunol."},{"key":"ref76","doi-asserted-by":"publisher","first-page":"e0429722","DOI":"10.1128\/spectrum.04297-22","article-title":"Effects of stool sample preservation methods on gut microbiota biodiversity: new original data and systematic review with Meta-analysis","volume":"11","author":"Li","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"134297","DOI":"10.1016\/j.neulet.2019.134297","article-title":"Alteration of the fecal microbiota in north-eastern Han Chinese population with sporadic Parkinson\u2019s disease","volume":"707","author":"Li","year":"2019","journal-title":"Neurosci. Lett."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1007\/s11427-016-9001-4","article-title":"Structural changes of gut microbiota in Parkinson\u2019s disease and its correlation with clinical features","volume":"60","author":"Li","year":"2017","journal-title":"Sci. China Life Sci."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/s12974-019-1528-y","article-title":"Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson\u2019s disease","volume":"16","author":"Lin","year":"2019","journal-title":"J. Neuroinflammation"},{"key":"ref80","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.parkreldis.2018.05.007","article-title":"Gut microbiota in patients with Parkinson\u2019s disease in southern China","volume":"53","author":"Lin","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref81","doi-asserted-by":"publisher","first-page":"881872","DOI":"10.3389\/fnagi.2022.881872","article-title":"Nutritional intake and gut microbiome composition predict Parkinson\u2019s disease","volume":"14","author":"Lubomski","year":"","journal-title":"Front. Aging Neurosci."},{"key":"ref82","doi-asserted-by":"publisher","first-page":"875261","DOI":"10.3389\/fnagi.2022.875261","article-title":"The gut microbiome in Parkinson\u2019s disease: a longitudinal study of the impacts on disease progression and the use of device-assisted therapies","volume":"14","author":"Lubomski","year":"","journal-title":"Front. Aging Neurosci."},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1498756","DOI":"10.3389\/fnagi.2024.1498756","article-title":"Global, regional, national epidemiology and trends of Parkinson\u2019s disease from 1990 to 2021: findings from the global burden of disease study 2021","volume":"16","author":"Luo","year":"2025","journal-title":"Front. Aging Neurosci."},{"key":"ref84","volume-title":"Silva 138.1 prokaryotic SSU taxonomic training data formatted for DADA2","author":"McLaren","year":"2021"},{"key":"ref85","doi-asserted-by":"publisher","first-page":"e61217","DOI":"10.1371\/journal.pone.0061217","article-title":"Phyloseq: an R package for reproducible interactive analysis and graphics of microbiome census data","volume":"8","author":"McMurdie","year":"2013","journal-title":"PLoS One"},{"key":"ref86","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12866-023-02933-7","article-title":"Study of the gut microbiome in Egyptian patients with Parkinson\u2019s disease","volume":"23","author":"Mehanna","year":"2023","journal-title":"BMC Microbiol."},{"key":"ref87","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1111\/ene.14644","article-title":"Gut microbiota and metabolome distinctive features in Parkinson disease: focus on levodopa and levodopa-carbidopa intrajejunal gel","volume":"28","author":"Melis","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"e0187307","DOI":"10.1371\/journal.pone.0187307","article-title":"Progression of Parkinson\u2019s disease is associated with gut dysbiosis: two-year follow-up study","volume":"12","author":"Minato","year":"2017","journal-title":"PLoS One"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s12866-019-1519-2","article-title":"Assessment of the impact of different fecal storage protocols on the microbiota diversity and composition: a pilot study","volume":"19","author":"Moossavi","year":"2019","journal-title":"BMC Microbiol."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","article-title":"Motor symptoms in Parkinson\u2019s disease: a unified framework","volume":"68","author":"Moustafa","year":"2016","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1080\/21678421.2020.1772825","article-title":"Progression and survival of patients with motor neuron disease relative to their fecal microbiota","volume":"21","author":"Ngo","year":"2020","journal-title":"Amyotroph. Lateral Scler. Frontotemporal Degener."},{"key":"ref92","doi-asserted-by":"publisher","first-page":"e105\u2013e125","DOI":"10.1016\/S2468-2667(21)00249-8","article-title":"Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019","volume":"7","author":"Nichols","year":"2022","journal-title":"Lancet Public Health"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"e00797-20","DOI":"10.1128\/mSystems.00797-20","article-title":"Short-chain fatty acid-producing gut microbiota is decreased in Parkinson\u2019s disease but not in rapid-eye-movement sleep behavior disorder","volume":"5","author":"Nishiwaki","year":"","journal-title":"mSystems"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41531-022-00328-5","article-title":"Short chain fatty acids-producing and mucin-degrading intestinal bacteria predict the progression of early Parkinson\u2019s disease","volume":"8","author":"Nishiwaki","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref95","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1002\/mds.28119","article-title":"Meta-analysis of gut dysbiosis in Parkinson\u2019s disease","volume":"35","author":"Nishiwaki","year":"","journal-title":"Mov. Disord."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"109566","DOI":"10.1016\/j.neuropharm.2023.109566","article-title":"Differences in the gut microbiome across typical ageing and in Parkinson\u2019s disease","volume":"235","author":"Nuzum","year":"2023","journal-title":"Neuropharmacology"},{"key":"ref97","volume-title":"Vegan community ecology package version 2.6-2","author":"Oksanen","year":"2022"},{"key":"ref98","doi-asserted-by":"publisher","first-page":"e0173004","DOI":"10.1371\/journal.pone.0173004","article-title":"Pili-like proteins of Akkermansia muciniphila modulate host immune responses and gut barrier function","volume":"12","author":"Ottman","year":"2017","journal-title":"PLoS One"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.3390\/cells9071687","article-title":"Inflammation in Parkinson\u2019s disease: mechanisms and therapeutic implications","volume":"9","author":"Pajares","year":"2020","journal-title":"Cells"},{"key":"ref100","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/B978-0-12-815249-2.00028-2","article-title":"The microbiome and metabolome in alcoholic liver disease","volume-title":"Microbiome and metabolome in diagnosis, therapy, and other strategic applications","author":"Patel","year":"2019"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"908","DOI":"10.4103\/aian.aian_460_23","article-title":"Dysbiosis of the beneficial gut Bacteria in patients with Parkinson\u2019s disease from India","volume":"26","author":"Pavan","year":"2023","journal-title":"Ann. Indian Acad. Neurol."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s12223-022-00977-2","article-title":"Exploring the multifactorial aspects of gut microbiome in Parkinson\u2019s disease","volume":"67","author":"Pavan","year":"2022","journal-title":"Folia Microbiol. (Praha)"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1186\/s12883-025-04191-8","article-title":"Global, regional and national burden of Parkinson\u2019s disease in people over 55 years of age: a systematic analysis of the global burden of disease study, 1991\u20132021","volume":"25","author":"Peng","year":"2025","journal-title":"BMC Neurol."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41531-022-00300-3","article-title":"Multiomics implicate gut microbiota in altered lipid and energy metabolism in Parkinson\u2019s disease","volume":"8","author":"Pereira","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref105","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1007\/s10517-017-3700-7","article-title":"Analysis of gut microbiota in patients with Parkinson\u2019s disease","volume":"162","author":"Petrov","year":"2017","journal-title":"Bull. Exp. Biol. Med."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/nm.4236","article-title":"A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice","volume":"23","author":"Plovier","year":"2017","journal-title":"Nat. Med."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref109","doi-asserted-by":"publisher","first-page":"D590","DOI":"10.1093\/nar\/gks1219","article-title":"The SILVA ribosomal RNA gene database project: improved data processing and web-based tools","volume":"41","author":"Quast","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref110","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1053\/j.gastro.2011.07.043","article-title":"Global and deep molecular analysis of microbiota signatures in fecal samples from patients with irritable bowel syndrome","volume":"141","author":"Rajili\u0107-Stojanovi\u0107","year":"2011","journal-title":"Gastroenterology"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.12688\/f1000research.14528.1","article-title":"An early diagnosis is not the same as a timely diagnosis of Parkinson\u2019s disease","volume":"7","author":"Rees","year":"2018","journal-title":"F1000Res"},{"key":"ref112","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3389\/fneur.2020.00137","article-title":"Gut microbiota altered in mild cognitive impairment compared with Normal cognition in sporadic Parkinson\u2019s disease","volume":"11","author":"Ren","year":"2020","journal-title":"Front. Neurol."},{"key":"ref113","doi-asserted-by":"publisher","first-page":"3655","DOI":"10.1128\/AEM.04050-14","article-title":"Akkermansia muciniphila adheres to enterocytes and strengthens the integrity of the epithelial cell layer","volume":"81","author":"Reunanen","year":"2015","journal-title":"Appl. Environ. Microbiol."},{"key":"ref114","doi-asserted-by":"publisher","first-page":"e1005752","DOI":"10.1371\/journal.pcbi.1005752","article-title":"mixOmics: an R package for \u2018omics feature selection and multiple data integration","volume":"13","author":"Rohart","year":"2017","journal-title":"PLoS Comput. Biol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1038\/s41531-021-00156-z","article-title":"Meta-analysis of the Parkinson\u2019s disease gut microbiome suggests alterations linked to intestinal inflammation","volume":"7","author":"Romano","year":"2021","journal-title":"Npj Park. Dis"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"794640","DOI":"10.3389\/fneur.2021.794640","article-title":"Mediterranean diet adherence in people with Parkinson\u2019s disease reduces constipation symptoms and changes fecal microbiota after a 5-week single-arm pilot study","volume":"12","author":"Rusch","year":"2021","journal-title":"Front. Neurol."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"e00561-20","DOI":"10.1128\/msystems.00561-20","article-title":"Gut microbiota and metabolome alterations associated with Parkinson\u2019s disease","volume":"5","author":"Sarah","year":"2020","journal-title":"mSystems"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"636545","DOI":"10.3389\/fnagi.2021.636545","article-title":"The association between the gut microbiota and Parkinson\u2019s disease, a Meta-analysis","volume":"13","author":"Shen","year":"2021","journal-title":"Front. Aging Neurosci."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1007\/s00253-023-12410-w","article-title":"The alteration of intestinal mucosal \u03b1-synuclein expression and mucosal microbiota in Parkinson\u2019s disease","volume":"107","author":"Shi","year":"2023","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"ref120","volume-title":"Parkinsonism","author":"Shrimanker","year":"2024"},{"key":"ref121","doi-asserted-by":"publisher","first-page":"25","DOI":"10.3389\/fendo.2020.00025","article-title":"The role of short-chain fatty acids from gut microbiota in gut-brain communication","volume":"11","author":"Silva","year":"2020","journal-title":"Front. Endocrinol."},{"key":"ref122","doi-asserted-by":"publisher","first-page":"e080952","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"BMJ"},{"key":"ref123","doi-asserted-by":"publisher","first-page":"878239","DOI":"10.3389\/fnins.2022.878239","article-title":"Update to the treatment of Parkinson\u2019s disease based on the gut-brain axis mechanism","volume":"16","author":"Sun","year":"2022","journal-title":"Front. Neurosci."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/s41531-022-00327-6","article-title":"Probiotics synergized with conventional regimen in managing Parkinson\u2019s disease","volume":"8","author":"Sun","year":"2022","journal-title":"NPJ Parkinsons Dis."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","article-title":"Selective neuronal vulnerability in Parkinson disease","volume":"18","author":"Surmeier","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"ref126","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1159\/000441768","article-title":"Reduced abundance of butyrate-producing Bacteria species in the fecal microbial Community in Crohn\u2019s disease","volume":"93","author":"Takahashi","year":"2016","journal-title":"Digestion"},{"key":"ref127","doi-asserted-by":"publisher","first-page":"e0126685","DOI":"10.1371\/journal.pone.0126685","article-title":"The effect of sampling and storage on the fecal microbiota composition in healthy and diseased subjects","volume":"10","author":"Tedjo","year":"2015","journal-title":"PLoS One"},{"key":"ref128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.parkreldis.2021.11.017","article-title":"Gut microbiome in Parkinson\u2019s disease: new insights from meta-analysis","volume":"94","author":"Toh","year":"2022","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref129","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.parkreldis.2016.08.019","article-title":"Short chain fatty acids and gut microbiota differ between patients with Parkinson\u2019s disease and age-matched controls","volume":"32","author":"Unger","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref130","doi-asserted-by":"publisher","first-page":"1468645","DOI":"10.3389\/fcimb.2024.1468645","article-title":"Impact of antibiotic prophylaxis on gut microbiota in colorectal surgery: insights from an Eastern European stewardship study","volume":"14","author":"V\u0103c\u0103rean-Trandafir","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"ref131","doi-asserted-by":"publisher","first-page":"1092771","DOI":"10.3389\/frmbi.2022.1092771","article-title":"The impact of cefuroxime prophylaxis on human intestinal microbiota in surgical oncological patients","volume":"1","author":"V\u0103c\u0103rean-Trandafir","year":"2023","journal-title":"Front. Microbiomes"},{"key":"ref132","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/gutjnl-2015-309618","article-title":"Stool consistency is strongly associated with gut microbiota richness and composition, enterotypes and bacterial growth rates","volume":"65","author":"Vandeputte","year":"2016","journal-title":"Gut"},{"key":"ref133","doi-asserted-by":"publisher","first-page":"101012","DOI":"10.1016\/j.bbih.2025.101012","article-title":"The emerging role of microbiota derived SCFAs in neurodegenerative disorders","volume":"46","author":"Wachamo","year":"2025","journal-title":"Brain Behav. Immun."},{"key":"ref134","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41531-020-0112-6","article-title":"Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens","volume":"6","author":"Wallen","year":"2020","journal-title":"NPJ Parkinsons Dis."},{"key":"ref135","doi-asserted-by":"publisher","first-page":"3685","DOI":"10.1038\/s41598-018-22094-2","article-title":"Xiexin Tang improves the symptom of type 2 diabetic rats by modulation of the gut microbiota","volume":"8","author":"Wei","year":"2018","journal-title":"Sci. Rep."},{"key":"ref136","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41531-019-0100-x","article-title":"Effect of Parkinson\u2019s disease and related medications on the composition of the fecal bacterial microbiota","volume":"5","author":"Weis","year":"2019","journal-title":"NPJ Parkinsons Dis."},{"key":"ref137","volume-title":"ggplot2: elegant graphics for data analysis (Cham: Springer)","author":"Wickham","year":"2016"},{"key":"ref138","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.3389\/fmicb.2019.02407","article-title":"Rarefaction, alpha diversity, and statistics","volume":"10","author":"Willis","year":"2019","journal-title":"Front. Microbiol."},{"key":"ref139","doi-asserted-by":"publisher","first-page":"105187","DOI":"10.1016\/j.micpath.2021.105187","article-title":"Alterations of gut microbiota and metabolome with Parkinson\u2019s disease","volume":"160","author":"Yan","year":"2021","journal-title":"Microb. Pathog."},{"key":"ref140","doi-asserted-by":"publisher","first-page":"5698","DOI":"10.3390\/jcm10235698","article-title":"Differences in the composition of gut microbiota between patients with Parkinson\u2019s disease and healthy controls: a cohort study","volume":"10","author":"Zapa\u0142a","year":"2021","journal-title":"J. Clin. Med."},{"key":"ref141","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3233\/JPD-223500","article-title":"Parkinson\u2019s disease and the gut microbiome in rural California","volume":"12","author":"Zhang","year":"2022","journal-title":"J. Parkinsons Dis."},{"key":"ref142","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1093\/gastro\/goab035","article-title":"Role of gut microbiota in functional constipation","volume":"9","author":"Zhang","year":"2021","journal-title":"Gastroenterol. Rep."},{"key":"ref143","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.parkreldis.2020.10.034","article-title":"Altered gut microbiota in Parkinson\u2019s disease patients\/healthy spouses and its association with clinical features","volume":"81","author":"Zhang","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref144","doi-asserted-by":"publisher","first-page":"1148546","DOI":"10.3389\/fnagi.2023.1148546","article-title":"Exploring the alteration of gut microbiota and brain function in gender-specific Parkinson\u2019s disease based on metagenomic sequencing","volume":"15","author":"Zhang","year":"2023","journal-title":"Front. Aging Neurosci."}],"container-title":["Frontiers in Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1654995\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T06:25:35Z","timestamp":1761891935000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnins.2025.1654995\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,31]]},"references-count":144,"alternative-id":["10.3389\/fnins.2025.1654995"],"URL":"https:\/\/doi.org\/10.3389\/fnins.2025.1654995","relation":{},"ISSN":["1662-453X"],"issn-type":[{"value":"1662-453X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,31]]},"article-number":"1654995"}}